NO743492L - Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series. - Google Patents
Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series.Info
- Publication number
- NO743492L NO743492L NO743492A NO743492A NO743492L NO 743492 L NO743492 L NO 743492L NO 743492 A NO743492 A NO 743492A NO 743492 A NO743492 A NO 743492A NO 743492 L NO743492 L NO 743492L
- Authority
- NO
- Norway
- Prior art keywords
- series
- preparation
- physiologically active
- prostaglandin compound
- substituted cyclopentane
- Prior art date
Links
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 title 1
- -1 prostaglandin compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B63—SHIPS OR OTHER WATERBORNE VESSELS; RELATED EQUIPMENT
- B63B—SHIPS OR OTHER WATERBORNE VESSELS; EQUIPMENT FOR SHIPPING
- B63B2211/00—Applications
- B63B2211/02—Oceanography
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27122072A | 1972-07-13 | 1972-07-13 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO743492L true NO743492L (en) | 1974-01-15 |
| NO144830B NO144830B (en) | 1981-08-10 |
| NO144830C NO144830C (en) | 1981-11-18 |
Family
ID=23034697
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2724/73A NO143741C (en) | 1972-07-13 | 1973-07-03 | ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES |
| NO743492A NO144830C (en) | 1972-07-13 | 1974-09-26 | SUBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE BY PREPARING A PHYSIOLOGY ACTIVE PROSTAGLAND CONNECTION OF THE E OR F SERIES |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2724/73A NO143741C (en) | 1972-07-13 | 1973-07-03 | ANALOGY PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLAND CONNECTIONS OF THE E AND F SERIES |
Country Status (25)
| Country | Link |
|---|---|
| JP (4) | JPS5241257B2 (en) |
| AR (2) | AR209064A1 (en) |
| AT (1) | AT367033B (en) |
| BE (1) | BE802231A (en) |
| CA (1) | CA1041495A (en) |
| CH (1) | CH593254A5 (en) |
| CS (1) | CS201027B2 (en) |
| DD (2) | DD116459A5 (en) |
| DE (1) | DE2334945A1 (en) |
| ES (4) | ES416865A1 (en) |
| FI (1) | FI57583C (en) |
| FR (1) | FR2192834B1 (en) |
| GB (1) | GB1446341A (en) |
| HU (4) | HU172058B (en) |
| IE (1) | IE37909B1 (en) |
| IL (2) | IL42691A (en) |
| IN (1) | IN138789B (en) |
| LU (1) | LU68015A1 (en) |
| NL (1) | NL7309792A (en) |
| NO (2) | NO143741C (en) |
| PH (1) | PH11461A (en) |
| SE (3) | SE7705947L (en) |
| SU (4) | SU644384A3 (en) |
| YU (1) | YU187773A (en) |
| ZA (1) | ZA734769B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| DE2463432C2 (en) * | 1974-04-03 | 1987-06-19 | Hoechst Ag, 6230 Frankfurt, De | |
| ZA747723B (en) * | 1974-12-11 | 1976-11-24 | Pfizer | 11-desoxy-15-substituted-omega-pentanor prostaglandins |
| US4149006A (en) * | 1977-01-24 | 1979-04-10 | G. D. Searle & Co. | Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain |
| GB8329559D0 (en) * | 1983-11-04 | 1983-12-07 | Erba Farmitalia | Furyl derivatives of 16-substituted prostaglandins preparations |
| SE9002596D0 (en) * | 1990-08-08 | 1990-08-08 | Pharmacia Ab | A METHOD OF SYNTHESIS OF PROSTAGLANDIN DERIVATIVES |
| US5972991A (en) * | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US6602900B2 (en) | 1992-09-21 | 2003-08-05 | Allergan, Inc. | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| KR100578616B1 (en) * | 2004-07-23 | 2006-05-10 | 한미약품 주식회사 | Method for preparing D-erythro-2,2-difluoro-2-deoxy-1-oxo ribose compound |
| JP2016539994A (en) * | 2013-12-13 | 2016-12-22 | アラーガン、インコーポレイテッドAllergan,Incorporated | Solid form of α, ω-disubstituted dihydroxycyclopentyl compounds and methods for their preparation and use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1324737A (en) * | 1970-11-02 | 1973-07-25 | Upjohn Co | Prostaglandins and the preparation thereof |
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| IL50311A (en) * | 1972-06-02 | 1977-08-31 | Pfizer | Dimethyl alkoxy-2-oxoalkyl phosphonates and their preparattion |
-
1973
- 1973-07-03 NO NO2724/73A patent/NO143741C/en unknown
- 1973-07-03 ES ES416865A patent/ES416865A1/en not_active Expired
- 1973-07-05 FI FI2162/73A patent/FI57583C/en active
- 1973-07-06 IN IN1575/CAL/73A patent/IN138789B/en unknown
- 1973-07-09 PH PH14802A patent/PH11461A/en unknown
- 1973-07-09 IL IL42691A patent/IL42691A/en unknown
- 1973-07-10 DE DE19732334945 patent/DE2334945A1/en not_active Withdrawn
- 1973-07-11 CS CS734994A patent/CS201027B2/en unknown
- 1973-07-12 SU SU731948945A patent/SU644384A3/en active
- 1973-07-12 HU HU73PI00000482A patent/HU172058B/en unknown
- 1973-07-12 DD DD180811*A patent/DD116459A5/xx unknown
- 1973-07-12 DD DD172243A patent/DD109210A5/xx unknown
- 1973-07-12 CA CA176,270A patent/CA1041495A/en not_active Expired
- 1973-07-12 HU HU73PI00000480A patent/HU171158B/en unknown
- 1973-07-12 CH CH1020673A patent/CH593254A5/xx not_active IP Right Cessation
- 1973-07-12 BE BE1005234A patent/BE802231A/en unknown
- 1973-07-12 HU HU73PI00000387A patent/HU171156B/en unknown
- 1973-07-12 HU HU73PI00000481A patent/HU171946B/en unknown
- 1973-07-13 AR AR249095A patent/AR209064A1/en active
- 1973-07-13 AT AT0620773A patent/AT367033B/en not_active IP Right Cessation
- 1973-07-13 ZA ZA734769A patent/ZA734769B/en unknown
- 1973-07-13 LU LU68015A patent/LU68015A1/xx unknown
- 1973-07-13 JP JP48079214A patent/JPS5241257B2/ja not_active Expired
- 1973-07-13 NL NL7309792A patent/NL7309792A/xx not_active Application Discontinuation
- 1973-07-13 GB GB3121773A patent/GB1446341A/en not_active Expired
- 1973-07-13 FR FR7325835A patent/FR2192834B1/fr not_active Expired
- 1973-07-13 IE IE1186/73A patent/IE37909B1/en unknown
- 1973-11-07 YU YU01877/73A patent/YU187773A/en unknown
-
1974
- 1974-05-06 AR AR253775A patent/AR214383A1/en active
- 1974-09-26 NO NO743492A patent/NO144830C/en unknown
-
1975
- 1975-04-26 ES ES437038A patent/ES437038A1/en not_active Expired
- 1975-04-26 ES ES437037A patent/ES437037A1/en not_active Expired
- 1975-04-26 ES ES437039A patent/ES437039A1/en not_active Expired
- 1975-09-05 SU SU752169008A patent/SU645563A3/en active
- 1975-09-09 SU SU7502170659A patent/SU584791A3/en active
- 1975-09-11 SU SU752171155A patent/SU645564A3/en active
-
1976
- 1976-08-19 IL IL50308A patent/IL50308A0/en unknown
- 1976-11-22 JP JP14060776A patent/JPS5293753A/en active Pending
- 1976-11-22 JP JP14060576A patent/JPS5297958A/en active Pending
- 1976-11-22 JP JP14060676A patent/JPS52122349A/en active Pending
-
1977
- 1977-05-20 SE SE7705947A patent/SE7705947L/en not_active Application Discontinuation
- 1977-05-20 SE SE7705946A patent/SE7705946L/en unknown
- 1977-05-20 SE SE7705945A patent/SE7705945L/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE418080B (en) | CFYCLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDE | |
| SE400280B (en) | 2-HALOGEN-4-SUBSTITUTED-6,7,8-TRIALCOXIKINAZOLINES FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALKOXIKINAZ | |
| NO141752C (en) | Substituted acetic acid esters for use as pesticides | |
| SE409707B (en) | PROCEDURE FOR THE PREPARATION OF SULFOXIDES, WHICH ARE ANTONONISTS AGAINST CERTAIN EFFECTS OF HISTAMIN | |
| SE422051B (en) | ALKYNYLYCYLOPROPANCARBOXYLIC ACID ESTERS FOR USE AS INSECTICIDES | |
| SE435289B (en) | O-SUBSTITUTED 7 BETA-AMINO-3-CEFEM-3-OL-4-CARBONIC ACID DERIVATIVES FOR USING AS INTERMEDIATE FOR THE PREPARATION OF O-SUBSTITUTED 7 BETA-ACYLAMINO-3-CEFEM-3-OL-4-OL-4-OL-4 | |
| SE411748B (en) | CYCLEOPROPANCARBOXYLIC ACID ESTERS FOR USE AS PESTICIDES | |
| SE417957B (en) | OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT | |
| SE398879B (en) | 1-AMINOURACILES FOR USE AS HERBICIDES | |
| NO149139C (en) | DIMETHYLOX OXPHOSPHONATES FOR USE AS BASIC MATERIAL IN THE PREPARATION OF PHYSIOLOGICALLY ACTIVE PROSTAGLANDINES | |
| NO743492L (en) | Substituted cyclopentane derivative for use as an intermediate in the preparation of a physiologically active prostaglandin compound of the E or F series. | |
| SE7601868L (en) | CARBONITRILES FOR USE AS INTERMEDIATE PRODUCTS | |
| SE395460B (en) | PROCEDURE FOR THE PREPARATION OF 2BETA, 16BETA-DIPIPERIDINO-5ALFA-ANDROSTANES | |
| SE411206B (en) | N-PHENYLAMINES FOR USE AS HERBICIDES | |
| SE416543B (en) | SIBSTITUTED CYCLOPENTAND DERIVATIVES FOR USE AS INTERMEDIATE IN THE PREPARATION OF PHARMACEUTICALLY ACTIVE PROSTAGLANDIN ANALOGS | |
| NO146280C (en) | BIS-TETRAHYDROPYRANYLETERS FOR USE AS INTERMEDIATE FOR PREPARING A PHYSIOLOGY ACTIVE P-BIFENYLESTER OF A PROSTAGLANDIN ANALOGUE OF THE E OR F SERIES | |
| DK137858B (en) | Naphthopyrans with amber character for use as fragrances. | |
| NO770869L (en) | 5-CYCLOHEXYL-1-INDANOL FOR USE AS A STARTING MATERIAL IN THE PREPARATION OF 5-CYCLOHEXYLINE DECOMPOSITIONS. | |
| SE399259B (en) | WAY TO REMOVE 2-AMINO-4-H-PYRANES, INTENDED FOR USE AS A DRUG | |
| AR205083A1 (en) | PROCEDURE FOR THE PREPARATION OF SULFON SALTS OF 2-5-DIHYDROXY BENZENOSULPHONIC ACIDS | |
| NO740849L (en) | Cyclopentanyl-tetrahydropyranyl-ether derivative for use in the preparation of physiologically active prostaglandins. | |
| SE403915B (en) | USE OF CHLORO-S-TRIAZINE DERIVATIVES AS ACTIVATIVES FOR A PEROXIDE INQUIRY | |
| SE398113B (en) | SUBSTITUTED DEODACADIANIC ACID ESTERS FOR USE AS INSECTICIDES | |
| SE411350B (en) | 15ALFA, 16ALFA-METHYLENE-4-PREGNENES FOR USE AS CONTRACTIVE AGENTS | |
| SE403476B (en) | CERTAIN 4-NITRODIFENYLETER DERIVATIVES USED AS ACARICIDES |